Cargando…

CD3/CD19 Depletion for T-cell Reduction of Allogeneic Transplants: Mostly Efficient, but not Robust

Aggressive T-cell depletion, in vitro or in vivo, is a prerequisite for survival of haplo-identical stem cell transplantation. The classical T-cell-depleted transplant, immunomagnetically enriched CD34+ cells, is very safe with respect to graft-versus-host reactivity, but associated with very high t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wiercinska, Eliza, Seifried, Erhard, Bonig, Halvard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Atlantis Press 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486974/ https://www.ncbi.nlm.nih.gov/pubmed/34820615 http://dx.doi.org/10.2991/chi.k.210725.001

Ejemplares similares

Allogeneic transplant procurement in the times of COVID-19: Quality report from the central European cryopreservation site
por: Wiercinska, Eliza, et al.
Publicado: (2021)

Preanalytic depletion of medicinal anti-CD38 antibody from patient plasma for immunohematology testing
por: Ehrend, Elisabeth, et al.
Publicado: (2021)

Albumin Modifies Responses to Hematopoietic Stem Cell Mobilizing Agents in Mice
por: Danner, Eva, et al.
Publicado: (2019)

Donor-intrinsic variables determine mobilization efficiency: analyses from a cohort of sixty twice-mobilized stem cell donors
por: Kim-Wanner, Soo-Zin, et al.
Publicado: (2020)

SARS‐CoV‐2‐specific T cells are generated in less than half of allogeneic HSCT recipients failing to seroconvert after COVID‐19 vaccination
por: Jarisch, Andrea, et al.
Publicado: (2022)

Sufficient blood, safe blood: can we have both?
por: Bönig, Halvard, et al.
Publicado: (2012)

Erythrocyte depletion from bone marrow: performance evaluation after 50 clinical-scale depletions with Spectra Optia BMC
por: Kim-Wanner, Soo-Zin, et al.
Publicado: (2017)

Protein arginine methyltransferase 6 controls erythroid gene expression and differentiation of human CD34(+) progenitor cells
por: Herkt, Stefanie C., et al.
Publicado: (2018)

Variant rs1801157 in the 3’UTR of SDF-1ß Does Not Explain Variability of Healthy-Donor G-CSF Responsiveness
por: Schulz, Miriam, et al.
Publicado: (2015)

Automation of cellular therapy product manufacturing: results of a split validation comparing CD34 selection of peripheral blood stem cell apheresis product with a semi-manual vs. an automatic procedure
por: Hümmer, Christiane, et al.
Publicado: (2016)

Generation and validation of a formula to calculate hemoglobin loss on a cohort of healthy adults subjected to controlled blood loss
por: Hahn-Klimroth, Max, et al.
Publicado: (2021)

Antithymocyte globulin exposure in CD34(+) T-cell–depleted allogeneic hematopoietic cell transplantation
por: Lakkaraja, Madhavi, et al.
Publicado: (2022)

Immune Responses to SARS-CoV-2 Vaccination in Young Patients with Anti-CD19 Chimeric Antigen Receptor T Cell-Induced B Cell Aplasia
por: Jarisch, Andrea, et al.
Publicado: (2022)

FUSE binding protein 1 (FUBP1) expression is upregulated by T-cell acute lymphocytic leukemia protein 1 (TAL1) and required for efficient erythroid differentiation
por: Steiner, Marlene, et al.
Publicado: (2019)

T-Cell Depleted Haploidentical Transplantation in Children With Hematological Malignancies: A Comparison Between CD3+/CD19+ and TCRαβ+/CD19+ Depletion Platforms
por: Gonzalez-Vicent, Marta, et al.
Publicado: (2022)

Hematopoietic-Extrinsic Cues Dictate Circadian Redistribution of Mature and Immature Hematopoietic Cells in Blood and Spleen
por: Stenzinger, Miriam, et al.
Publicado: (2019)

Results of a multicenter phase I/II trial of TCRαβ and CD19-depleted haploidentical hematopoietic stem cell transplantation for adult and pediatric patients
por: Bethge, Wolfgang A., et al.
Publicado: (2021)

Hematopoietic transcription factors and differential cofactor binding regulate PRKACB isoform expression
por: Kuvardina, Olga N., et al.
Publicado: (2017)

Ocrelizumab Depletes CD20(+) T Cells in Multiple Sclerosis Patients
por: Gingele, Stefan, et al.
Publicado: (2018)

Allogeneic Stem Cell Transplantation with CD34+ Cell Selection
por: Roldan, Elisa, et al.
Publicado: (2019)

CD4+ T cells are the major predictor of HCMV control in allogeneic stem cell transplant recipients on letermovir prophylaxis
por: Lauruschkat, Chris David, et al.
Publicado: (2023)

The Most Promising Biomarkers of Allogeneic Kidney Transplant Rejection
por: Rogulska, Karolina, et al.
Publicado: (2022)

PRMT6 activates cyclin D1 expression in conjunction with the transcription factor LEF1
por: Schneider, Lucas, et al.
Publicado: (2021)

Allogeneic CD19-CAR-T cell infusion after allogeneic hematopoietic stem cell transplantation in B cell malignancies
por: Liu, Jun, et al.
Publicado: (2017)

CD4+ T cells in aged or thymectomized recipients of allogeneic stem cell transplantations
por: Takahashi, Hiroshi, et al.
Publicado: (2015)

Targeting the CD27-CD70 Pathway to Improve Outcomes in Both Checkpoint Immunotherapy and Allogeneic Hematopoietic Cell Transplantation
por: Lutfi, Forat, et al.
Publicado: (2021)

In vitro migration and proliferation (“wound healing”) potential of mesenchymal stromal cells generated from human CD271(+) bone marrow mononuclear cells
por: Latifi-Pupovci, Hatixhe, et al.
Publicado: (2015)

The transcription factor TAL1 and miR-17-92 create a regulatory loop in hematopoiesis
por: Meyer, Annekarin, et al.
Publicado: (2020)

Non-traditional CD4+CD25−CD69+ regulatory T cells are correlated to leukemia relapse after allogeneic hematopoietic stem cell transplantation
por: Zhao, Xiao-su, et al.
Publicado: (2014)

CD19‐CAR engineered NK‐92 cells are sufficient to overcome NK cell resistance in B‐cell malignancies
por: Romanski, Annette, et al.
Publicado: (2016)

Low Toxicity and Favorable Overall Survival in Relapsed/Refractory B-ALL following CAR T cells and CD34-selected T Cell Depleted Allogeneic Hematopoietic Cell Transplant.
por: Fabrizio, Vanessa A., et al.
Publicado: (2020)

Polyclonal CD5+/CD19+ B1a lymphocytes after allogeneic stem cell transplantation: a potential diagnostic pitfall
por: Qorbani, Amir, et al.
Publicado: (2020)

Intrathecal anti-CD20 efficiently depletes meningeal B cells in CNS autoimmunity
por: Lehmann-Horn, Klaus, et al.
Publicado: (2014)

Efficient B Cell Depletion via Diphtheria Toxin in CD19-Cre/iDTR Mice
por: Demircik, Filiz, et al.
Publicado: (2013)

P1271: THE IMPACT OF CYTOMEGALOVIRUS-SPECIFIC T CELLS USAGE AS ADOPTIVE THERAPY IN PATIENTS WITH PT-CY AND TCR ΑΒ+/CD19+ CELLS DEPLETION AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Dmitrova, Anna, et al.
Publicado: (2023)

Mobilization of hematopoietic stem cells with the novel CXCR4 antagonist POL6326 (balixafortide) in healthy volunteers—results of a dose escalation trial
por: Karpova, Darja, et al.
Publicado: (2017)

Joint Modeling of Immune Reconstitution Post Haploidentical Stem Cell Transplantation in Pediatric Patients With Acute Leukemia Comparing CD34(+)-Selected to CD3/CD19-Depleted Grafts in a Retrospective Multicenter Study
por: Salzmann-Manrique, Emilia, et al.
Publicado: (2018)

Isolation of a Highly Purified HSC-enriched CD34(+)CD90(+)CD45RA(−) Cell Subset for Allogeneic Transplantation in the Nonhuman Primate Large-animal Model
por: Radtke, Stefan, et al.
Publicado: (2020)

Effects of T-Cell Depletion on Allogeneic Hematopoietic Stem Cell Transplantation Outcomes in AML Patients
por: Hobbs, Gabriela Soriano, et al.
Publicado: (2015)

CD19xCD3 DART protein mediates human B-cell depletion in vivo in humanized BLT mice
por: Tsai, Perry, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_levskt3hanqc29f285tu8u6u8p